Type
Internal restructuring
Country
Germany
Region
Baden-Württemberg; Stuttgart;
Location of affected unit(s)
Rangendingen
Sector
Manufacturing
Manufacturing Of Furniture And Other Manufacturing
Other Manufacturing
32 - Other manufacturing

260 jobs
Number of planned job losses
Job loss
Announcement Date
23 February 2010
Employment effect (start)
Foreseen end date
1 October 2011

Description

Abbott, a global research, manufacturing and service company specialising in pharmaceutical research, medical instruments and health care announced it is to lay off 260 workers by closing one of its three German locations. The manufacturing plant at Rangendingen will be shut by the third quarter of 2011, the company said before starting talks with the works council. The products - medical instruments such as catheters and stents - are said to be old-fashioned compared with those produced at Abbott plants in Ireland and California. Overcapacity has also been given as a reason for plant closure. Abbott acquired the Rangendingen plant in 2003. The closure will affect all 260 jobs - one fifth of the local workforce. Abbott retains a large number of German workers, some 5000 in total.


Sources

Citation

Eurofound (2010), Abbott, Internal restructuring in Germany, factsheet number 70442, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/70442.